What is a stock summary page? Click here for an overview.
Business Description
Hemostemix Inc
NAICS : 325412
SIC : 3741
ISIN : CA4236941080
Description
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -54.86 | |||||
| Debt-to-Equity | -0.55 | |||||
| Debt-to-EBITDA | -1.58 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 53.5 | |||||
| 3-Year EPS without NRI Growth Rate | 48 | |||||
| 3-Year FCF Growth Rate | 54.9 | |||||
| 3-Year Book Growth Rate | -62 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.81 | |||||
| 9-Day RSI | 30.09 | |||||
| 14-Day RSI | 35.21 | |||||
| 3-1 Month Momentum % | 215.3 | |||||
| 6-1 Month Momentum % | 130.17 | |||||
| 12-1 Month Momentum % | 151.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.04 | |||||
| Quick Ratio | 0.04 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.2 | |||||
| Shareholder Yield % | -2.57 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1149.75 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -6.7 | |||||
| EV-to-EBITDA | -6.7 | |||||
| EV-to-FCF | -77.1 | |||||
| Earnings Yield (Greenblatt) % | -14.93 | |||||
| FCF Yield % | -1.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HMTXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hemostemix Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.035 | ||
| Beta | 0.85 | ||
| 3-Year Sharpe Ratio | 0.39 | ||
| 3-Year Sortino Ratio | 1.04 | ||
| Volatility % | 225.51 | ||
| 14-Day RSI | 35.21 | ||
| 14-Day ATR ($) | 0.01307 | ||
| 20-Day SMA ($) | 0.107321 | ||
| 12-1 Month Momentum % | 151.09 | ||
| 52-Week Range ($) | 0.024 - 0.285 | ||
| Shares Outstanding (Mil) | 140.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hemostemix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hemostemix Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hemostemix Inc Frequently Asked Questions
What is Hemostemix Inc(HMTXF)'s stock price today?
The current price of HMTXF is $0.08. The 52 week high of HMTXF is $0.28 and 52 week low is $0.02.
When is next earnings date of Hemostemix Inc(HMTXF)?
The next earnings date of Hemostemix Inc(HMTXF) is .
Does Hemostemix Inc(HMTXF) pay dividends? If so, how much?
Hemostemix Inc(HMTXF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers